ovarian carcinoma

Ovarian carcinoma is the leading cause of death due to gynecological malignancies (Alvarez et al., 1999), and > 70% of patients face a relapse and ultimately die of their disease (Rauh-Hain et al., 2011).

Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.

The results of histological examination revealed a high grade serous ovarian carcinoma (Figure 5).

In this report, we describe 2 cases of papillary neck metastases that were eventually diagnosed as tumors unrelated to the thyroid: an ovarian carcinoma and a renal cell carcinoma (RCC).

Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.

None of the 51 patients, who were followed to the end of the study, developed evidence of ovarian carcinoma. Abnormal abdominal ultrasound scans in 163 patients resulted in 3 diagnoses of malignancy.

Distant metastasis in epithelial ovarian carcinoma. Cancer 1987;60(7):1561-1566.

Background: Our preliminary data on the protein expression of 5ORT1 in ovarian carcinoma tissues showed that sortilin was overexpressed in ovarian carcinoma patients and cell lines, while non-malignant ovaries expressed comparably lower amount of this protein.

In nulliparous women, repeated ovulations and rupture of ovarian surfaces predisposes to ovarian carcinoma.Most patients having ovarian carcinoma presented with abdominal mass and pain which is similar to the results reported in a study by Junejo et al21.

[sup][16] Telomerase activity and dysfunctional telomeres have been demonstrated in human ovarian carcinoma. [sup][17] Telomerase is not present in the normal ovarian surface epithelium and premalignant lesions, but is upregulated in 90-97% of ovarian carcinomas.

Indeed, it has recently been shown that innate tumor features determine cytoreductibility of women with ovarian carcinoma; preoperative CA-125 and P53 can determine if the tumor would be cytoreductible or not.